Scarica il Dossier - Ordine dei Medici di Bologna

DOSSIER
51. Zullo A, Hassan C, De Francesco V, Marignani M, Angeletti S, Porto D, et al. A third-line
levofloxacin-based rescue therapy for Helicobacter pylori eradication. Dig Liver Dis 2003; 35:
232-6.
52. Gisbert J, De La Morena F. Systematic review and meta-analysis: levofloxacin-based rescue regimens
after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 2006; 23: 35-44.
53. Saad R, Schoenfeld P, Kim HM, Chey WD. Levofloxacin-based triple therapy versus bismuthbased
quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am J Gastroenterol
2006; 101: 488-96.
54. Nista AC. Candelli M, Cremonini F, Cazzato IA, Di Caro S, Gabrielli M. Levofloxacin-based
triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized
trial. Aliment Pharmacol Ther 2003; 18: 627-33.
55. Bilardi C, Dulbecco P, Zentilin P, Reglioni S, Iiritano E, Parodi A, et al. A 10-day levofloxacin-based
therapy in patients with resistant Helicobacter pylori infection: a controlled trial. Clin
Gastroenterol Hepatol 2004; 2: 997-1002.
56. Zullo A, De Francesco V, Hassan C, Panella C, Morini S, Ierardi E. Second-line treatment
for Helicobacter pylori eradication after sequential therapy failure: a pilot study. Therapy 2006; 3:
251-4.
57. Caselli M, Zullo A, Maconi G, Parente F, Alvisi V, Casetti T, et al. Cervia II Working Group
Report 2006: Guidelines on diagnosis and treatment of Helicobacter pylori infection. Dig Liver Dis
2007; 39: 782-89.
58. Vakil N, Vaira D. Sequential therapy for Helicobacter pylori: time to consider making the switch
JAMA 2008; 300 (11): 1346-7.
XIV • Bollettino Notiziario • Dossier 5/2008